Rapamycin conditioning of dendritic cells differentiated from human ES cells promotes a tolerogenic phenotype.
While human embryonic stem cells (hESCs) may one day facilitate the treatment of degenerative diseases requiring cell replacement therapy, the success of regenerative medicine is predicated on overcoming the rejection of replacement tissues. Given the role played by dendritic cells (DCs) in the esta...
Auteurs principaux: | Silk, K, Leishman, A, Nishimoto, K, Reddy, A, Fairchild, P |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2012
|
Documents similaires
-
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
par: Sachamitr, P, et autres
Publié: (2018) -
Differentiation of dendritic cells from human embryonic stem cells.
par: Silk, K, et autres
Publié: (2011) -
Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset
par: Patty Sachamitr, et autres
Publié: (2018-01-01) -
Pharmacological manipulation of dendritic cells in the pursuit of transplantation tolerance.
par: Leishman, A, et autres
Publié: (2011) -
Tolerogenicity is not an absolute property of a dendritic cell.
par: Farquhar, C, et autres
Publié: (2010)